Search results
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 hours agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 2 days agoOn the stock market today, Moderna stock surged 12.7% to 125.59. Shares topped a...Beat During the...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 2 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider...follow blueprint for success, including guidance on building...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 3 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 2 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna, Inc. price | Moderna, Inc. Quote Zacks Rank & Key Picks Moderna currently carries a Zacks...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks· 6 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 2 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...
Risk of uveitis recurrence higher in year after COVID vaccination
Center for Infectious Disease Research and Policy· 6 days agoThe odds of the condition were increased among recipients of all 4 vaccines studied: Pfizer, Moderna...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 6 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
